These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 11472249)

  • 1. Antiinflamatory agents less dangerous for gastrointestinal tract.
    Rodríguez-Téllez M; Argüelles F; Herrerías JM; Ledro D; Esteban J; Herrerías JM
    Curr Pharm Des; 2001 Jul; 7(10):951-76. PubMed ID: 11472249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Recommendation for the prevention and treatment of non-steroidal anti-inflammatory drug-induced gastrointestinal ulcers and its complications].
    ;
    Zhonghua Nei Ke Za Zhi; 2017 Jan; 56(1):81-85. PubMed ID: 28056333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Challenges in managing NSAID-associated gastrointestinal tract injury.
    Goldstein JL
    Digestion; 2004; 69 Suppl 1():25-33. PubMed ID: 15001832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The gastrointestinal effects of nonselective NSAIDs and COX-2-selective inhibitors.
    Laine L
    Semin Arthritis Rheum; 2002 Dec; 32(3 Suppl 1):25-32. PubMed ID: 12528071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitric oxide-releasing nonsteroidal anti-inflammatory drugs: gastrointestinal-sparing potential drugs.
    Singh R; Kumar R; Singh DP
    J Med Food; 2009 Feb; 12(1):208-18. PubMed ID: 19298218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastrointestinal toxicity of non-steroidal anti-inflammatory drugs: the effect of nimesulide compared with naproxen on the human gastrointestinal tract.
    Bjarnason I; Thjodleifsson B
    Rheumatology (Oxford); 1999 May; 38 Suppl 1():24-32. PubMed ID: 10369403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastroprotective therapy and risk of gastrointestinal ulcers: risk reduction by COX-2 therapy.
    Wolfe F; Anderson J; Burke TA; Arguelles LM; Pettitt D
    J Rheumatol; 2002 Mar; 29(3):467-73. PubMed ID: 11908558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastro-intestinal lesions induced by non-steroidal anti-inflammatory drugs.
    Albu R; Dragomir P; Voiosu R
    Rom J Intern Med; 1998; 36(3-4):145-59. PubMed ID: 10822511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Role of gastric acid and neutrophils in NSAID-induced microcirculatory disturbance].
    Uchiyama K; Yoshida N
    Nihon Rinsho; 2007 Oct; 65(10):1768-75. PubMed ID: 17926522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NSAID-associated adverse effects and acid control aids to prevent them: a review of current treatment options.
    Naesdal J; Brown K
    Drug Saf; 2006; 29(2):119-32. PubMed ID: 16454539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative toxicity of nonsteroidal anti-inflammatory drugs.
    McCarthy DM
    Am J Med; 1999 Dec; 107(6A):37S-46S; discussion 46S-47S. PubMed ID: 10628592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual acting anti-inflammatory drugs: a reappraisal.
    Bertolini A; Ottani A; Sandrini M
    Pharmacol Res; 2001 Dec; 44(6):437-50. PubMed ID: 11735348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study.
    Silverstein FE; Faich G; Goldstein JL; Simon LS; Pincus T; Whelton A; Makuch R; Eisen G; Agrawal NM; Stenson WF; Burr AM; Zhao WW; Kent JD; Lefkowith JB; Verburg KM; Geis GS
    JAMA; 2000 Sep; 284(10):1247-55. PubMed ID: 10979111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonsteroidal anti-inflammatory drugs: how do they damage gastroduodenal mucosa?
    Scarpignato C
    Dig Dis; 1995 Jan; 13 Suppl 1():9-39. PubMed ID: 7697906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonsteroidal anti-inflammatory drug gastropathy.
    Laine L
    Gastrointest Endosc Clin N Am; 1996 Jul; 6(3):489-504. PubMed ID: 8803564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastrointestinal effects of selective and non-selective non-steroidal anti-inflammatory drugs.
    Akarca US
    Curr Pharm Des; 2005; 11(14):1779-93. PubMed ID: 15892675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonsteroidal antiinflammatory drugs and the gastrointestinal tract.
    Hirschowitz BI
    Gastroenterologist; 1994 Sep; 2(3):207-23. PubMed ID: 7987619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastrointestinal mucosal injury following repeated daily oral administration of conventional formulations of indometacin and other non-steroidal anti-inflammatory drugs to pigs: a model for human gastrointestinal disease.
    Rainsford KD; Stetsko PI; Sirko SP; Debski S
    J Pharm Pharmacol; 2003 May; 55(5):661-8. PubMed ID: 12831509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylaxis and treatment of NSAID-induced gastroduodenal disorders.
    La Corte R; Caselli M; Castellino G; Bajocchi G; Trotta F
    Drug Saf; 1999 Jun; 20(6):527-43. PubMed ID: 10392669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NSAID-induced gastrointestinal damage and the design of GI-sparing NSAIDs.
    Wallace JL; Vong L
    Curr Opin Investig Drugs; 2008 Nov; 9(11):1151-6. PubMed ID: 18951293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.